Showing codes 10370-348-11 Memantine Hydrochloride — 10370-538-01 Guanfacine

10370-348-11 - Memantine Hydrochloride
Firm: Par Pharmaceutical, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-348-11)
Usage type: ORAL
HTML TXT

10370-349-09 - Memantine Hydrochloride
Firm: Par Pharmaceutical, Inc.
Package Description: 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-349-09)
Usage type: ORAL
HTML TXT

10370-349-11 - Memantine Hydrochloride
Firm: Par Pharmaceutical, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-349-11)
Usage type: ORAL
HTML TXT

10370-365-01 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-01)
Usage type: ORAL
HTML TXT

10370-365-05 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-05)
Usage type: ORAL
HTML TXT

10370-365-11 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-11)
Usage type: ORAL
HTML TXT

10370-366-01 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-366-01)
Usage type: ORAL
HTML TXT

10370-366-05 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-366-05)
Usage type: ORAL
HTML TXT

10370-366-11 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-366-11)
Usage type: ORAL
HTML TXT

10370-367-01 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-367-01)
Usage type: ORAL
HTML TXT

10370-367-05 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-367-05)
Usage type: ORAL
HTML TXT

10370-367-11 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-367-11)
Usage type: ORAL
HTML TXT

10370-368-01 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-01)
Usage type: ORAL
HTML TXT

10370-368-05 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-05)
Usage type: ORAL
HTML TXT

10370-368-11 - Topiramate
Firm: ENDO USA, Inc.
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-368-11)
Usage type: ORAL
HTML TXT

10370-390-01 - Nifedipine
Firm: Par Pharmaceutical, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-390-01)
Usage type: ORAL
HTML TXT

10370-390-30 - Nifedipine
Firm: Par Pharmaceutical, Inc.
Package Description: 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-390-30)
Usage type: ORAL
HTML TXT

10370-391-01 - Nifedipine
Firm: Par Pharmaceutical, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-391-01)
Usage type: ORAL
HTML TXT

10370-391-30 - Nifedipine
Firm: Par Pharmaceutical, Inc.
Package Description: 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-391-30)
Usage type: ORAL
HTML TXT

10370-392-01 - Nifedipine
Firm: Par Pharmaceutical, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-392-01)
Usage type: ORAL
HTML TXT

10370-510-10 - Divalproex Sodium
Firm: Par Pharmaceutical, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-510-10)
Usage type: ORAL
HTML TXT

10370-510-50 - Divalproex Sodium
Firm: Par Pharmaceutical, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-510-50)
Usage type: ORAL
HTML TXT

10370-511-10 - Divalproex Sodium
Firm: Par Pharmaceutical, Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-511-10)
Usage type: ORAL
HTML TXT

10370-511-50 - Divalproex Sodium
Firm: Par Pharmaceutical, Inc.
Package Description: 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-511-50)
Usage type: ORAL
HTML TXT

10370-533-01 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-533-01)
Usage type: ORAL
HTML TXT

10370-533-10 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-533-10)
Usage type: ORAL
HTML TXT

10370-534-01 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-534-01)
Usage type: ORAL
HTML TXT

10370-534-10 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-534-10)
Usage type: ORAL
HTML TXT

10370-536-01 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-536-01)
Usage type: ORAL
HTML TXT

10370-536-10 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-536-10)
Usage type: ORAL
HTML TXT

10370-538-01 - Guanfacine
Firm: Par Pharmaceutical Inc.
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (10370-538-01)
Usage type: ORAL
HTML TXT

Current Page # is: 1512
Ones	0	1	2	3	4	5	6	7	8	9
Tens	0	1	2	3	4	5	6	7	8	9
Hundreds	0	1	2	3	4	5	6	7	8	9
Thousands	0	1	2	3	4	5	6	7	8	9
Tens of Thousands	0	1